Related Experiment Videos
Effect of procainamide on induced ventricular tachycardia
Clinical Pharmacology and Therapeutics
|September 1, 1978
Summary
Procainamide often fails to prevent sustained ventricular tachycardia. Its antiarrhythmic effect stems from slowed conduction, not prolonged refractoriness, highlighting the need to assess drug efficacy on sustained arrhythmias.
Area of Science:
- Cardiology
- Electrophysiology
- Pharmacology
Background:
- Chronic recurrent ventricular tachycardia poses a significant clinical challenge.
- Assessing antiarrhythmic drug efficacy is crucial for patient management.
Purpose of the Study:
- To evaluate the effectiveness of procainamide in preventing inducible sustained ventricular tachycardia.
- To elucidate the electrophysiological mechanisms underlying procainamide's antiarrhythmic effects.
Main Methods:
- Ventricular extrastimulation was performed in 11 patients before and after procainamide infusion.
- Induction of sustained ventricular tachycardia was assessed using programmed electrical stimulation.
- Electrophysiological parameters including refractoriness and tachycardia cycle length were measured.
Main Results:
- Procainamide failed to prevent inducible sustained ventricular tachycardia in 6 of 7 patients.
- The mechanism of action appeared to be slowed conduction rather than prolonged refractoriness.
- Tachycardia cycle length was consistently prolonged post-procainamide administration.
Conclusions:
- Procainamide may often be ineffective in preventing sustained ventricular tachycardia.
- Slowed conduction is the primary antiarrhythmic mechanism of procainamide.
- Drug efficacy evaluation should focus on sustained arrhythmias, not isolated ectopic beats.